Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Human Platelet Lysate Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Human Platelet Lysate Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Heparin
      • 1.3.3 Heparin free
    • 1.4 Market Segment by Application
      • 1.4.1 Global Human Platelet Lysate Market Share by Application (2019-2025)
      • 1.4.2 Biopharmaceutical companies
      • 1.4.3 Contract research organizations
      • 1.4.4 Academic & research institutes
      • 1.4.5 Pharmaceutical companies
      • 1.4.6 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Human Platelet Lysate Production Value 2014-2025
      • 2.1.2 Global Human Platelet Lysate Production 2014-2025
      • 2.1.3 Global Human Platelet Lysate Capacity 2014-2025
      • 2.1.4 Global Human Platelet Lysate Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Human Platelet Lysate Market Size CAGR of Key Regions
      • 2.2.2 Global Human Platelet Lysate Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Human Platelet Lysate Capacity by Manufacturers
      • 3.1.2 Global Human Platelet Lysate Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Human Platelet Lysate Revenue by Manufacturers (2014-2019)
      • 3.2.2 Human Platelet Lysate Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Human Platelet Lysate Market Concentration Ratio (CR5 and HHI)
    • 3.3 Human Platelet Lysate Price by Manufacturers
    • 3.4 Key Manufacturers Human Platelet Lysate Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Human Platelet Lysate Market
    • 3.6 Key Manufacturers Human Platelet Lysate Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Heparin Production and Production Value (2014-2019)
      • 4.1.2 Heparin free Production and Production Value (2014-2019)
    • 4.2 Global Human Platelet Lysate Production Market Share by Type
    • 4.3 Global Human Platelet Lysate Production Value Market Share by Type
    • 4.4 Human Platelet Lysate Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Human Platelet Lysate Consumption by Application

    6 Production by Regions

    • 6.1 Global Human Platelet Lysate Production (History Data) by Regions 2014-2019
    • 6.2 Global Human Platelet Lysate Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Human Platelet Lysate Production Growth Rate 2014-2019
      • 6.3.2 United States Human Platelet Lysate Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Human Platelet Lysate Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Human Platelet Lysate Production Growth Rate 2014-2019
      • 6.4.2 European Union Human Platelet Lysate Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Human Platelet Lysate Import & Export
    • 6.5 China
      • 6.5.1 China Human Platelet Lysate Production Growth Rate 2014-2019
      • 6.5.2 China Human Platelet Lysate Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Human Platelet Lysate Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Human Platelet Lysate Consumption by Regions

    • 7.1 Global Human Platelet Lysate Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Human Platelet Lysate Consumption by Type
      • 7.2.2 United States Human Platelet Lysate Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Human Platelet Lysate Consumption by Type
      • 7.3.2 European Union Human Platelet Lysate Consumption by Application
    • 7.4 China
      • 7.4.1 China Human Platelet Lysate Consumption by Type
      • 7.4.2 China Human Platelet Lysate Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Human Platelet Lysate Consumption by Type
      • 7.5.2 Rest of World Human Platelet Lysate Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Mill Creek Life Sciences
      • 8.1.1 Mill Creek Life Sciences Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Human Platelet Lysate
      • 8.1.4 Human Platelet Lysate Product Introduction
      • 8.1.5 Mill Creek Life Sciences Recent Development
    • 8.2 Merck & Co., Inc
      • 8.2.1 Merck & Co., Inc Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Human Platelet Lysate
      • 8.2.4 Human Platelet Lysate Product Introduction
      • 8.2.5 Merck & Co., Inc Recent Development
    • 8.3 STEMCELL Technologies Inc
      • 8.3.1 STEMCELL Technologies Inc Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Human Platelet Lysate
      • 8.3.4 Human Platelet Lysate Product Introduction
      • 8.3.5 STEMCELL Technologies Inc Recent Development
    • 8.4 AventaCell BioMedical
      • 8.4.1 AventaCell BioMedical Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Human Platelet Lysate
      • 8.4.4 Human Platelet Lysate Product Introduction
      • 8.4.5 AventaCell BioMedical Recent Development
    • 8.5 Compass Biomedical, Inc
      • 8.5.1 Compass Biomedical, Inc Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Human Platelet Lysate
      • 8.5.4 Human Platelet Lysate Product Introduction
      • 8.5.5 Compass Biomedical, Inc Recent Development
    • 8.6 Macopharma SA
      • 8.6.1 Macopharma SA Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Human Platelet Lysate
      • 8.6.4 Human Platelet Lysate Product Introduction
      • 8.6.5 Macopharma SA Recent Development
    • 8.7 Trinova Biochem GmbH
      • 8.7.1 Trinova Biochem GmbH Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Human Platelet Lysate
      • 8.7.4 Human Platelet Lysate Product Introduction
      • 8.7.5 Trinova Biochem GmbH Recent Development
    • 8.8 PL BioScience GmbH
      • 8.8.1 PL BioScience GmbH Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Human Platelet Lysate
      • 8.8.4 Human Platelet Lysate Product Introduction
      • 8.8.5 PL BioScience GmbH Recent Development
    • 8.9 Cook Regentec
      • 8.9.1 Cook Regentec Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Human Platelet Lysate
      • 8.9.4 Human Platelet Lysate Product Introduction
      • 8.9.5 Cook Regentec Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Human Platelet Lysate Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Human Platelet Lysate Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Human Platelet Lysate Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Human Platelet Lysate Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Human Platelet Lysate Production Forecast by Type
      • 9.7.2 Global Human Platelet Lysate Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Human Platelet Lysate Sales Channels
      • 10.2.2 Human Platelet Lysate Distributors
    • 10.3 Human Platelet Lysate Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Human platelet lysate (HPL) is a non-animal derived cell culture growth supplement obtained from blood platelets after freezing and thawing. HPL contains abundant growth factors and cytokines necessary for cell growth and proliferation. Platelet lysate can be used as a source of growth factors to replace bovine serum in cell culture medium. Replacing bovine serum with HPL allows expansion and clinical grade production of functional mesenchymal stromal cells by removing the risk of xenogeneic immune reactions and transmission of bovine prion and viral pathogens.
      In 2019, the market size of Human Platelet Lysate is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Human Platelet Lysate.

      This report studies the global market size of Human Platelet Lysate, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Human Platelet Lysate production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Mill Creek Life Sciences
      Merck & Co., Inc
      STEMCELL Technologies Inc
      AventaCell BioMedical
      Compass Biomedical, Inc
      Macopharma SA
      Trinova Biochem GmbH
      PL BioScience GmbH
      Cook Regentec

      Market Segment by Product Type
      Heparin
      Heparin free

      Market Segment by Application
      Biopharmaceutical companies
      Contract research organizations
      Academic & research institutes
      Pharmaceutical companies
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Human Platelet Lysate status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Human Platelet Lysate manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Human Platelet Lysate are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now